Evidence map›Paper›PMID 27049061›Full record

ArticleMucosal immunology2017

Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.

D Paquin-Proulx, C Ching, I Vujkovic-Cvijin, D Fadrosh, L Loh, Y Huang, M Somsouk, S V Lynch, P W Hunt, D F Nixon and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Preferential and persistent impact of acute HIV-1 infection on CD4Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Gut Innate Immunity and HIV Pathogenesis.Current HIV/AIDS reports · 2021
    Review
  13. Review
  14. The gut microbiome and frailty.Translational research : the journal of laboratory and clinical medicine · 2020
    Review
  15. HIV, Sexual Orientation, and Gut Microbiome Interactions.Digestive diseases and sciences · 2020
    Review
  16. Review
  17. Article
  18. Observational
  19. Review
  20. The impact ofGut microbes · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

D Paquin-ProulxDepartment of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.
C ChingDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
I Vujkovic-CvijinDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
D FadroshDivision of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
L LohDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Y HuangDepartment of Bioengineering and Therapeutic Sciences, School of Pharmacy University of California, San Francisco, California, USA.
M SomsoukDivision of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
S V LynchDivision of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
P W HuntHIV/AIDS Division, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.
D F NixonDepartment of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, District of Columbia, USA.
D SenGuptaDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
University of California, San Francisco · USGeorge Washington University · USSan Francisco General Hospital · USUniversity of Melbourne · AU

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI MICHAEL Ilya BUKRINSKY · 2015 to 2026
$29.6M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
The District of Columbia Developmental Center for AIDS Research (DC D-CFAR)P30AI087714 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI GREENBERG, ALAN EDWARD · 2010 to 2014
$8.4M
Innate NKT Cells in HIV InfectionR37AI052731 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2007 to 2016
$3.1M
Innate NKT Cells in HIV InfectionR01AI052731 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2002 to 2006
$2.1M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
HIV, Gut Mucosal Turnover and Inflammation, and the Risk of Colorectal NeoplasiaK23CA157929 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOMSOUK, MA · 2011 to 2014
$687k
Determining the role of human endogenous retroviruses (HERV) in HIV-1 infectionK08AI100680 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SENGUPTA, DEVI · 2012 to 2015
$525k
NCI NIH HHS K23 CA157929NCRR NIH HHS UL1 RR024131NIAID NIH HHS HHSN272201300006CNIAID NIH HHS K08 AI100680NIAID NIH HHS K24 AI069994NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI087714NIAID NIH HHS P30 AI117970NIAID NIH HHS R01 AI052731NIAID NIH HHS R24 AI067039NIAID NIH HHS R37 AI052731NIAID NIH HHS U19 AI096109NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells are innate-like T cells that respond to lipid antigens presented by CD1d. These immunoregulatory cells have the capacity for rapid cytokine release after antigen recognition and are essential for the activation of multiple arms of the immune response. HIV-1 infection is associated with iNKT cell depletion in the peripheral blood; however, their role in the gastrointestinal-associated lymphoid tissue (GALT) is less well studied. Our results show that iNKT cells are found at a higher frequency in GALT compared with blood, particularly in HIV-1 elite controllers. The capacity of iNKT cells to produce interleukin-4 (IL-4) and IL-10 in the GALT was associated with less immune activation and lower markers of microbial translocation, whereas regulatory T cell frequency showed positive associations with immune activation. We hypothesized that the composition of the microbiota would influence iNKT cell frequency and function. We found positive associations between the abundance of several Bacteroides species and iNKT cell frequency and their capacity to produce IL-4 in the GALT but not in the blood. Overall, our results are consistent with the hypothesis that GALT iNKT cells, influenced by certain bacterial species, may have a key role in regulating immune activation in HIV-1 infection.

Indexed as

AdultAgedAntigens, CD1dBacteroidesCells, CulturedFemaleGastrointestinal MicrobiomeHIV-1HIV InfectionsHumansImmunity, InnateInterleukin-10Interleukin-4IntestinesLipidsMaleAntigens, CD1dInterleukin-10Interleukin-4Lipids

Identifiers

PMID27049061
PMCPMC5053825
OpenAlexW2323471282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.